The prevalence of M. tuberculosis infection and disease in HIV positive individuals in Shiraz, Southern Iran

Iranian Red Crescent Medical Journal

Volumn 11, Issue 2, 2009, Pages 199-202

  Davarpanah, M A ^a   Rafiee, G H ^b   Mehrabani, Davood ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coinfection; HIV; M. tuberculosis; Prevalence; Sothern Iran

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CULTURE MEDIUM; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IRAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; WESTERN BLOTTING;

EID: 67649389609     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report, 2008.
2. Bock NN, Nadol P, Rogers M, Fenley MA, Moore J, Miller B. Provider-initiated HIV testing and counseling in TB clinical settings: tools for program implementation. Int J Tuberc Lung Dis 2008; 12:69-72. [18302826]
3. Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res 2004;120:277-89. [15520482]
4. Otsuka Y, Fujino T, Mori N, Sekiguchi J, Toyota E, Saruta K, Kikuchi Y, Sasaki Y, Ajisawa A, Otsuka Y, Nagai H, Takahara M, Saka H, Shirasaka T, Yamashita Y, Kiyosuke M, Koga H, Oka S, Kimura S, Mori T, Kuratsuji T, Kirikae T. Survey of human immunodeficiency virus (HIV)-seropositive patients with mycobacterial infection in Japan. J Infec 2005; 51:364-74. [16321647] [doi:10.1016/j.jinf.2004.12.015]
5. David AM, Mercado SP, Becker D, Edmundo K, Mugisha F. The prevention and control of HIV/AIDS, TB and Vector-borne diseases in informal settlements: challenges, opportunities and insights. J Urban Health 2007;84:i65-74. [17431796] [doi:10.1007 /s11524-007-9183-5]
6. Johnson MD, Decker CF. Tuberculosis and HIV infection. Dis Mon 2006;52:420-7. [17157614] [doi:10.1016/j.disamonth.2006.09.006]
7. Antas PR, Ding L, Hackman J, Reeves-Hammock L, Shintani AK, Schiffer J, Holland SM, Sterling TR. Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis. J Allergy Clin Immunol 2006;117:916-23. [16630952] [doi:10.1016/ j.jaci.2006.01.042]
8. García-García ML, Valdespino-Gómez JL, García-Sancho C, Mayar-Maya ME, Palacios-Martínez M, Balandrano-Campos S, Escobar-Gutiérrez A, Peruga A, Weissenbacher M, Daniels E. Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel. Int J Epidemiol 2000; 29:369-75. [10817138] [doi:10.1093 /ije/29.2.369]
9. Martins MV, Lima MC, Duppre NC, Matos HJ, Spencer JS, Brennan PJ, Sarno EN, Fonseca L, Pereira GM, Pessolani MC. The level of PPD-specific IFN-gamma-producing CD4+ T cells in the blood predicts the in vivo response to PPD. Tuberculosis (Edinb) 2007;87:202-11. [17049309]
10. Gordin FM, Dolin R, Masue H, Saag MS, Editors. AIDS therapy. 2nd ed. Philadelphia, USA: Elsevier Science Health Division, 2003: pp. 459-474.
11. Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Osmond D, Wallace JM, Rosen MJ, Reichman LB. Tuberculin and anergy testing in HIV-seropositive and HIVseronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med 1993; 119:185-93. [8100692]
12. Mohraz M, Ramezani A, Gachkar L, Velayati AA. Frequency of positive purified protein derivative test in those infected with human immunodeficiency virus. Arch Iran Med 2006;9:218-21. [16859054]
13. Goletti D, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, Munsiff SS, Ortona L, Cauda R, Fauci AS. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271-8. [8757635]
14. World Health Organization. Guidelines for implementing collaborative TB and HIV programs, WHO report. Geneva: WHO; 2003.
15. Mahajan A, Tandon VR, Verma S, Singh JB, Sharma M. Prevalence of tuberculosis, hepatitis B, hepatitis C and syphilis co-infections among HIV/AIDS patients. Indian J Med Microbiol 2008;26:196-7. [18445966] [doi:10.4103/0255-0857.40544]
16. Murcia-Aranguren MI, Gómez-Marin JE, Alvarado FS, Bustillo JG, de Mendivelson E, Gómez B, León CI, Triana WA, Vargas EA, Rodríguez E. Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogota, Colombia. BMC Infect Dis 2001; 1:21. [11722797] [doi:10.1186/1471-2334-1-21]
17. Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Wilcosky TC, Wallace JM, Rosen MJ, Reichman LB. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann Intern Med 1997;126:123-32. [9005746]